118 related articles for article (PubMed ID: 12662357)
1. Susceptibility of human and murine Chlamydia trachomatis serovars to granulocyte- and epithelium-derived antimicrobial peptides.
Chong-Cerrillo C; Selsted ME; Peterson EM; de la Maza LM
J Pept Res; 2003 May; 61(5):237-42. PubMed ID: 12662357
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Chlamydia trachomatis to protegrins and defensins.
Yasin B; Harwig SS; Lehrer RI; Wagar EA
Infect Immun; 1996 Mar; 64(3):709-13. PubMed ID: 8641770
[TBL] [Abstract][Full Text] [Related]
3. A cumulative experience examining the effect of natural and synthetic antimicrobial peptides vs. Chlamydia trachomatis.
Yasin B; Pang M; Wagar EA
J Pept Res; 2004 Aug; 64(2):65-71. PubMed ID: 15251032
[TBL] [Abstract][Full Text] [Related]
4. Activity of cathelicidin peptides against Chlamydia spp.
Donati M; Di Leo K; Benincasa M; Cavrini F; Accardo S; Moroni A; Gennaro R; Cevenini R
Antimicrob Agents Chemother; 2005 Mar; 49(3):1201-2. PubMed ID: 15728927
[TBL] [Abstract][Full Text] [Related]
5. Chlamydial-Secreted Protease Chlamydia High Temperature Requirement Protein A (cHtrA) Degrades Human Cathelicidin LL-37 and Suppresses Its Anti-Chlamydial Activity.
Dong X; Zhang W; Hou J; Ma M; Zhu C; Wang H; Hou S
Med Sci Monit; 2020 Jul; 26():e923909. PubMed ID: 32634134
[TBL] [Abstract][Full Text] [Related]
6. Protegrins: structural requirements for inactivating elementary bodies of Chlamydia trachomatis.
Yasin B; Lehrer RI; Harwig SS; Wagar EA
Infect Immun; 1996 Nov; 64(11):4863-6. PubMed ID: 8890254
[TBL] [Abstract][Full Text] [Related]
7. Activity of Novispirin G-10, a novel antimicrobial peptide against Chlamydia trachomatis and vaginosis-associated bacteria.
Yasin B; Pang M; Lehrer RI; Wagar EA
Exp Mol Pathol; 2003 Apr; 74(2):190-5. PubMed ID: 12710952
[TBL] [Abstract][Full Text] [Related]
8. Increasing effect of a high dose of PG-1 peptide on the infectivity of Chlamydophila abortus.
Donati M; Di Francesco A; Gennaro R; Benincasa M; Di Paolo M; Shurdhi A; Ostanello F; Baldelli R; Cevenini R
FEMS Immunol Med Microbiol; 2010 Jul; 59(2):221-2. PubMed ID: 20482624
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the Growth of
Nogueira AT; Braun KM; Carabeo RA
Front Cell Infect Microbiol; 2017; 7():438. PubMed ID: 29067282
[No Abstract] [Full Text] [Related]
10. In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K.
Donati M; Di Francesco A; D'Antuono A; Delucca F; Shurdhi A; Moroni A; Baldelli R; Cevenini R
Antimicrob Agents Chemother; 2010 Dec; 54(12):5379-80. PubMed ID: 20855744
[TBL] [Abstract][Full Text] [Related]
11. Chlamydia-secreted protease CPAF degrades host antimicrobial peptides.
Tang L; Chen J; Zhou Z; Yu P; Yang Z; Zhong G
Microbes Infect; 2015 Jun; 17(6):402-8. PubMed ID: 25752416
[TBL] [Abstract][Full Text] [Related]
12. Anti-chlamydial effect of plant peptides.
Balogh EP; Mosolygó T; Tiricz H; Szabó AM; Karai A; Kerekes F; Virók DP; Kondorosi E; Burián K
Acta Microbiol Immunol Hung; 2014 Jun; 61(2):229-39. PubMed ID: 24939689
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of intracellular multiplication of human strains of Chlamydia trachomatis by nitric oxide.
Igietseme JU; Uriri IM; Chow M; Abe E; Rank RG
Biochem Biophys Res Commun; 1997 Mar; 232(3):595-601. PubMed ID: 9126319
[TBL] [Abstract][Full Text] [Related]
14. Human Oral Defensins Antimicrobial Peptides: A Future Promising Antimicrobial Drug.
Khurshid Z; Zafar MS; Naseem M; Khan RS; Najeeb S
Curr Pharm Des; 2018; 24(10):1130-1137. PubMed ID: 29611481
[TBL] [Abstract][Full Text] [Related]
15. Cationic peptides: a new source of antibiotics.
Hancock RE; Lehrer R
Trends Biotechnol; 1998 Feb; 16(2):82-8. PubMed ID: 9487736
[TBL] [Abstract][Full Text] [Related]
16. Examination of Chlamydia trachomatis infection in environments mimicking normal and abnormal vaginal pH.
Yasin B; Pang M; Wagar EA; Lehrer RI
Sex Transm Dis; 2002 Sep; 29(9):514-9. PubMed ID: 12218842
[TBL] [Abstract][Full Text] [Related]
17. Killing of Giardia lamblia by cryptdins and cationic neutrophil peptides.
Aley SB; Zimmerman M; Hetsko M; Selsted ME; Gillin FD
Infect Immun; 1994 Dec; 62(12):5397-403. PubMed ID: 7960119
[TBL] [Abstract][Full Text] [Related]
18. Cyclic Peptides as Novel Therapeutic Microbicides: Engineering of Human Defensin Mimetics.
Falanga A; Nigro E; De Biasi MG; Daniele A; Morelli G; Galdiero S; Scudiero O
Molecules; 2017 Jul; 22(7):. PubMed ID: 28726740
[TBL] [Abstract][Full Text] [Related]
19. An in vitro model for immune control of chlamydial growth in polarized epithelial cells.
Igietseme JU; Wyrick PB; Goyeau D; Rank RG
Infect Immun; 1994 Aug; 62(8):3528-35. PubMed ID: 8039923
[TBL] [Abstract][Full Text] [Related]
20. Large-scale synthesis and functional elements for the antimicrobial activity of defensins.
Raj PA; Antonyraj KJ; Karunakaran T
Biochem J; 2000 May; 347 Pt 3(Pt 3):633-41. PubMed ID: 10769165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
